{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:31:33Z","timestamp":1780407093441,"version":"3.54.1"},"reference-count":8,"publisher":"Japanese Association of Rehabilitation Medicine","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PRM"],"published-print":{"date-parts":[[2018]]},"DOI":"10.2490\/prm.20180018","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T18:45:25Z","timestamp":1541011525000},"page":"n\/a","source":"Crossref","is-referenced-by-count":1,"title":["Convalescent Rehabilitation for an Elderly Patient with Giant Cell Myocarditis: Case Report"],"prefix":"10.2490","volume":"3","author":[{"given":"Hideki","family":"Arai","sequence":"first","affiliation":[{"name":"Toyonaka Heisei Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Toyonaka Heisei Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Morisawa","sequence":"additional","affiliation":[{"name":"Hyogo University of Health Sciences, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1338","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Ekstr\u00f6m K, Lehtonen J, Kandolin R, R\u00e4is\u00e4nen-Sokolowski A, Salmenkivi K, Kupari M: Long-term outcome and its predictors in giant cell myocarditis. Eur J Heart Fail 2016;18:1452\u20131458. PMID:27407025, DOI:10.1002\/ejhf.606","DOI":"10.1002\/ejhf.606"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Ooka J, Tanaka H, Hatani Y, Tsuji Y, Takeshige R, Mori S, Matsumoto K, Hara S, Tanaka H, Okita Y, Hirata K: Treatment of fulminant giant cell myocarditis associated with polymyositis using a left ventricular assist device and subsequent corticosteroid and immunosuppressive therapy leading to remission. Intern Med 2017;56:2155\u20132158. PMID:28781324, DOI:10.2169\/internalmedicine.8639-16","DOI":"10.2169\/internalmedicine.8639-16"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Kandolin R, Lehtonen J, Salmenkivi K, R\u00e4is\u00e4nen-Sokolowski A, Lommi J, Kupari M: Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression. Circ Heart Fail 2013;6:15\u201322. PMID:23149495, DOI:10.1161\/CIRCHEARTFAILURE.112.969261","DOI":"10.1161\/CIRCHEARTFAILURE.112.969261"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Yanagi H, Shindo N: Effects of exercise therapy on polymyositis complicated by post-myocarditis cardiomyopathy: A case report. J Rehabil Med 2017;49:282\u2013285. PMID:28218333, DOI:10.2340\/16501977-2206","DOI":"10.2340\/16501977-2206"},{"key":"5","unstructured":"5. JCS joint working group: Guidelines for Rehabilitation in Patients with Cardiovascular Disease (JCS2012). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2012_nohara_h.pdf (cited 2018 April 5)."},{"key":"6","unstructured":"6. Clinical Guideline Committee of The Japanese Association of Rehabilitation Medicine: Guideline for Safety Management and Promotion in Rehabilitation Medicine [in Japanese], Ishiyaku Pub, Inc, Tokyo, 2006."},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Cooper LT, Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, Bailey KR, Cunningham MW, Dec GW, Giant Cell Myocarditis Treatment Trial Investigators: Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 2008;102:1535\u20131539. PMID:19026310, DOI:10.1016\/j.amjcard.2008.07.041","DOI":"10.1016\/j.amjcard.2008.07.041"},{"key":"8","unstructured":"8. Barry JM, James EU, Robert OB, Rick AN, Michael JA, Mark Estes N.A., III, Leslie TC, Mark SL, Martin SM: Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: Hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: A scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015; 66:2362\u20132371."}],"container-title":["Progress in Rehabilitation Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/prm\/3\/0\/3_20180018\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T23:55:48Z","timestamp":1544226948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/prm\/3\/0\/3_20180018\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":8,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2490\/prm.20180018","relation":{},"ISSN":["2432-1354"],"issn-type":[{"value":"2432-1354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}